Navigation Links
Gloucester Pharmaceuticals Receives Fast Track Designation for,Romidepsin in Peripheral T-Cell Lymphoma

Designation

The Fast Track program is designed to facilitate and expedite the development and review of new products that demonstrate the potential to address an unmet medical need for serious or life-threatening conditions. A New Drug Application (NDA) for a Fast Track product may be submitted in sections on a rolling basis, rather than simultaneously. Fast Track designation may further lead to a priority review of an NDA within a 6 month timeframe.

About Special Protocol Assessment

A Special Protocol Assessment is a request for feedback from the FDA that allows a company to receive official evaluation and guidance on the design and size of pivotal clinical trial protocols. A company can request this formal assessment on a pivotal trial that is intended to form the primary basis of an efficacy claim in a New Drug Application (NDA).

About PTCL

Peripheral T-cell lymphoma is a term which encompasses a number of different malignancies of T-cell origin that account for about 10-15% of all cases of non-Hodgkin's lymphoma. PTCL can occur at any age from young adulthood to old age and is slightly more common in men than in women. It is a particularly aggressive form of lymphoma with a short median duration of life expectancy (approximately two years) from diagnosis.

About Romidepsin

Romidepsin is a novel agent in a new class of anti-cancer drugs known as histone deacetylase inhibitors. The Company is conducting a pivotal phase II study of romidepsin for patients with cutaneous T-cell lymphoma (CTCL) and has initiated a pivotal phase II study for patients with peripheral T-cell lymphoma (PTCL). Romidepsin has received Orphan Drug Designation from the Food and Drug Administration (FDA) for the treatment of non-Hodgkin T-cell lymphomas, which includes CTCL and PTCL. In addition, the European Agency for the Evaluation of Medicinal Products (EMEA) has issued Orphan Drug status for the treatment of both CTCL and PTCL. Fast Track s
'"/>




Page: 1 2 3

Related medicine technology :

1. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting
2. Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib Combination in Non-Small Cell Lung Cancer Presented at American Association of Cancer Research Annual Meeting
3. Gloucester Pharmaceuticals Announces Multiple Presentations of Preclinical Romidepsin Data at American Association of Cancer Research Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

Post Your Comments:
(Date:12/1/2009)..., , GLEN BURNIE, Md., Dec. 1 ...agnostic service provider for home testing and eva...nced it has named Richard Hassett, M.D., as its ch...president of Matria Healthcare, during its growth ...o a $350 million industry leader in total populati...
(Date:12/1/2009)..., , CHICAGO, Dec. 1 At t...ety of North America (RSNA), Royal Philips Electro...Breast Workspace, a set of solutions that provides... breast images at one workspot to help drive quali...reast care, Philips will also highlight new capabi...
(Date:12/1/2009)..., , ALBUQUERQUE, N.M., Dec. 1 /PRNewswire/ -...s laboratory that discovers, develops and markets ...ointment of Scott Glenn as chairman of the company... ,, Prior to joining Exagen, Glenn was managing... of a number of successful biomedical companies in...
Breaking Medicine Technology:Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Too Few Americans Get HIV Test Early Enough 50100 1Too Few Americans Get HIV Test Early Enough 50100 2Too Few Americans Get HIV Test Early Enough 50100 3New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 1New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 2Your arteries on Wonder bread 50090 1Your arteries on Wonder bread 50090 2
...gh-Risk Infants Versus,Current Standard of Care an... RSV- Related Lower Respiratory Infections -, TORO...une, Inc.,today announced positive results from a ...f respiratory syncytial virus (RSV). The,trial com...antibody,(MAb) also known as Numax(R), with Synagi...
...Occurs at the 55th Annual,Clinical Meeting of the ...s, COLLEGEVILLE, Pa., May 09, 2007 /PRNewswire-Fir...eth , presented results from the,first Phase 3 stu...he treatment of moderate-to-severe vasomotor sympt... menopause. These studies showed,that women who to...
Other Medicine Technology:MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 2MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 3MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 4MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 5MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 6MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 7Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 2Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 3Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 5Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 6
(Date:12/1/2009)...ec. 1 First Mercury Fin..." or the "Company") announced today that on Novemb...terly cash dividend of $0.025 per share, to be pai...he close of business on December 15, 2009. ,,... First Mercury Financial Corporation provides insu...
(Date:12/1/2009)...ing, isolating behaviors jump from friend to frie...-- A new study suggests that lonely people attract...nely, too. , "Loneliness can spread from person...aration," said James H. Fowler, co-author of the s...al of Personality and Social Psychology , and prof...
(Date:12/1/2009)...tioners of any medical, legal or business requirin... of relief this week with the release of ,DictateO...ed over the holiday weekend, allows anyone require... so quickly and seamlessly using just the iPhone 3...ber 1, 2009 -- The iPhone App, released by Florida...
(Date:12/1/2009)...Dec. 1 Air Products (NYS...sly announced sale of the assets of its polyuretha...ane® and Versathane® tradenames to COIM ...rethane chemicals producer COIM SpA. ,, Includ...ility in Paulsboro, N.J. Terms of the agreement ar...
(Date:12/1/2009)...PRNewswire/ -- Abrazo Media Relations-- The Center.../ www.pedsorthopaedics.com ) located in Mesa, Ariz...Dr. J. Hunt Udall to its practice. ,, Dr. Udal...rgery after recently completing his fellowship tra...ts where he focused on adult and pediatric orthopa...
Breaking Medicine News(10 mins):Health News:Loneliness May Be Catching 2Health News:Loneliness May Be Catching 3Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2
...in automated,medication management, today unveiled...t remote dispensing system designed exclusively fo...eir care. , The company made the announcemen...stem are operating in Texas, and each,InSite unit ...
...tional, Inc. (Amex: BUF ), announced today the C...scuss current business conditions on Tuesday,Novem... number is,(866) 901-2585. The international call ... ctrego@minrad.com , (716) 85...
...e for anti-aging drug trials, study says , ...biomarkers that are highly accurate in determining...hers at California,s Buck Institute for Age Resear... changes in gene expression, and complex computer ...
...., the makers of,Carmex(R) lip balms, today unveil... association with the new site,s launch, the compa...rmex.com. , "We know that Carmex users are s...flects this lifestyle and enables our,customers to...
...ce advertising,agency, recently received two prest...dia (MM&M), a leading healthcare publication. ... and effectiveness in healthcare marketing. Mango...m/cgi-bin/prnh/20081119/AQW573 ) , (Logo: ...
... Larry King,turns 75. In conjunction with his birt...alth Solutions and the LAC+USC Camino de Salud Net...ala in Los Angeles. The,Foundation, which provides...to quintuple-bypass surgery. He decided then, he w...
Other Medicine News:Health News:Talyst Unveils InSite for Long-Term Care 2Health News:Talyst Unveils InSite for Long-Term Care 3Health News:Researchers ID Suite of Genes in Aging Process 2Health News:Carma Laboratories Launches New Carmex(R) Web Site; Unveils Top 10 Reasons for a Virtual Visit 2Health News:Mangos Wins Two Gold Awards 2Health News:The King of Hearts Helps Others Follow a Healthy Road 2Health News:The King of Hearts Helps Others Follow a Healthy Road 3Health News:The King of Hearts Helps Others Follow a Healthy Road 4
LICOX Brain Tissue Oxygen Monitoring System
Hough Hough Burr-Saw for Crurotomy
...iva Parkinson's Control Therapy uses electrical st...the most disabling motor symptoms of Parkinson's d...fe and effective adjunctive treatment option for m...rigidity, bradykinesia/akinesia and/or tremor whi...
...features over 600 TV lines of resolution with RGB,...emperature selections, scanning size selection and...l allows the user to easily set up and operate the...ness, chroma, phase, contrast, volume and aperture...
Medicine Products: